(G13*) Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere

More details coming soon

Icon
NaN% mortality rate associated with the disease systemic atrophies primarily affecting central nervous system in diseases classified elsewhere

Diagnosis systemic atrophies primarily affecting central nervous system in diseases classified elsewhere is diagnosed Prevalent in Women Only

0

Men receive the diagnosis systemic atrophies primarily affecting central nervous system in diseases classified elsewhere

0 (No mortality)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
0

Women receive the diagnosis systemic atrophies primarily affecting central nervous system in diseases classified elsewhere

0 (No mortality)

Died from this diagnosis.

Risk Group for the Disease systemic atrophies primarily affecting central nervous system in diseases classified elsewhere - Men and Women aged 0

Icon
No Cases of the Disease Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere identified in Men
Icon
Less common in men the disease occurs at Age 0-95+Less common in women the disease occurs at Age 0-95+
Icon
No Cases of the Disease Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere identified in Men

Disease Features systemic atrophies primarily affecting central nervous system in diseases classified elsewhere

Icon
Absence or low individual and public risk
Icon

Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere - what does this mean

Systemic atrophies primarily affecting the central nervous system in diseases classified elsewhere are caused by a combination of genetic and environmental factors. these diseases can cause the degeneration of nerve cells in the brain and spinal cord, leading to problems with movement, sensation, and cognition.

What happens during the disease - systemic atrophies primarily affecting central nervous system in diseases classified elsewhere

The best way to prevent systemic atrophies primarily affecting the central nervous system is to maintain a healthy lifestyle. This includes eating a balanced diet, exercising regularly, getting enough sleep, avoiding smoking and alcohol, and managing stress. Additionally, it is important to get regular check-ups with your doctor and to stay up-to-date with recommended immunizations. Finally, it is important to be aware of any family history of systemic atrophies and to be aware of any symptoms that may indicate an underlying condition.

Clinical Pattern

Systemic atrophies primarily affecting the central nervous system in diseases classified elsewhere is a condition characterized by progressive degeneration of the brain and spinal cord, resulting in a wide range of neurological symptoms including difficulty walking, impaired vision, difficulty speaking, and cognitive decline. It is often associated with other systemic diseases, including diabetes, lupus, and certain types of cancer. Treatment typically includes medications to reduce inflammation, physical therapy, and lifestyle modifications.

How does a doctor diagnose

More details coming soon

Treatment and Medical Assistance

More details coming soon
Icon
No Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere - Prevention

Systemic atrophies primarily affecting the central nervous system can be prevented by maintaining good hygiene, eating a healthy diet, exercising regularly, getting regular check-ups, and avoiding exposure to toxins or environmental hazards. additionally, vaccinations can help protect against certain types of infections that can lead to this condition.

Specified forms of the disease

(G13.0*) Paraneoplastic neuromyopathy and neuropathy
(G13.1*) Other systemic atrophy primarily affecting central nervous system in neoplastic disease
(G13.2*) Systemic atrophy primarily affecting central nervous system in myxoedema
(G13.8*) Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere